Anti-Human IgG2 antibody [12D6] (STJA0032558)

SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1
ImmunogenHuman IgG2
STJA0032558
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionMouse monoclonal anti-Human IgG2 for use in ELISA in Human samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsELISA
HostMouse
ReactivityHuman
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone ID12D6
IsotypeIgG1
ConjugationUnconjugated
Concentration1 mg/mL
PurificationAffinity Purified
Dilution RangeELISA 1:10000
FormulationLiquid in PBS containing 0.09% sodium azide as a preservative.
Storage InstructionStore at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.

Target Information

Gene SymbolIGHG2Uniprot ID=IGHG2_HUMAN"
ImmunogenHuman IgG2

Additional Info

Post Translational Modifications Glycosylation on Asn-176 is required for interaction with Fc receptors and ability to activate the complement pathway. (Microbial infection) Deglycosylation on Asn-176 by S.pyogenes EndoS or Endos2 endoglucosidases prevents interaction between immunoglobulin-gamma (IgG) and Fc receptors, impairing ability to activate the complement pathway.
Function Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.
Protein Name Immunoglobulin Heavy Constant Gamma 2
Ig Gamma-2 Chain C Region
Ig Gamma-2 Chain C Region Dot
Ig Gamma-2 Chain C Region Til
Ig Gamma-2 Chain C Region Zie
Cellular Localisation Isoform 1: Secreted
Isoform 2: Cell Membrane
Single-Pass Membrane Protein
Alternative Antibody Names Anti-Immunoglobulin Heavy Constant Gamma 2 antibody
Anti-Ig Gamma-2 Chain C Region antibody
Anti-Ig Gamma-2 Chain C Region Dot antibody
Anti-Ig Gamma-2 Chain C Region Til antibody
Anti-Ig Gamma-2 Chain C Region Zie antibody
Anti-IGHG2 antibody

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins